AstraZeneca’s Severe Asthma Drug Positive in Phase III – Zacks.com


Wall Street Journal

AstraZeneca's Severe Asthma Drug Positive in Phase III
Zacks.com
These randomized, double-blind, parallel-group, placebo-controlled studies evaluated the safety and efficacy of benralizumab as an add-on therapy in the treatment of severe uncontrolled asthma with eosinophilic inflammation in patients aged 12 years
AstraZeneca's Asthma Drug Shows Positive ResultsWall Street Journal
AstraZeneca set to go head to head against GSK with asthma drugFinancial Times
AstraZeneca asthma drug hits goal, to enter competitive marketReuters
FierceBiotech –The Guardian –Philadelphia Business Journal
all 34 news articles »

View full post on asthma – Google News

Leave a Reply

Your email address will not be published. Required fields are marked *